Thursday, 15 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 9, 2026

Ask an Advisor: I'm 47 With $1.87 Million But I'm ‘Burned Out' From My Stressful Career. Can I Retire Early at 51?

View original at finance.yahoo.com
Ask an Advisor: I'm 47 With $1.87 Million But I'm ‘Burned Out' From My Stressful Career. Can I Retire Early at 51? Help me! I read the column frequently-huge fan!I'm 47, married, and severely burned out after 25+ years in a fast-paced and stressful field…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Most people with Scott's assets and income sources would be able to comfortably retire at 51

    80% confidence

  • Retirement success is driven by whether assets can reliably support spending, not by portfolio size alone

    80% confidence

  • Scott is probably looking at a very active period for the next 15-20 years based on his age

    80% confidence

  • Actual Social Security benefit is likely to be meaningfully lower than statement estimates for early retirees

    80% confidence

  • Social Security statement estimates won't be accurate for early retirees because they assume continued earnings at current level

    80% confidence

  • People tend to spend more in early retirement years when active, with spending slowing with age and picking back up for health expenses

    80% confidence

  • Plans to sell primary residence in around three years and buy something all cash somewhere warm

    80% confidence

  • If spending needs are similar to average person, Scott can almost certainly retire at 51 with his assets

    80% confidence

  • Severely burned out after 25+ years in a fast-paced and stressful field

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Ask an Advisor: I'm 47 With $1.87 Million But I'm ‘Burned Out' From My Stressful Career. Can I Retire Early at 51? — Source | Via News | ViaNews EU